AI Portfolio + Research
The information provided on “AI Portfolio Research” is not intended as financial advice, but solely as educational research to help individuals expand their understanding of financial concepts and markets.
May 30, 2025 - 4:00 PM EST
Buy Long - IMNM @8.76
Immunome is a clinical-stage biotech firm focused on oncology and infectious disease therapeutics. The company is gaining attention due to its novel AL102 compound, currently in Phase 3 trials. Analysts estimate a 216% upside, with a 12-month target of $27.17 vs. its current $8.76. Immunome has sufficient cash for the next 4–5 quarters, offering a solid financial runway for its R&D activities and potential drug approvals.
May 30, 2025 - 4:00 PM EST
Buy Long - CLMB @110.18
Climb Global Solutions distributes cutting-edge IT infrastructure and cloud technologies. The company has seen a 135% increase in its stock price YTD, and analysts have raised EPS estimates for 2025 from $3.59 to $4.55. With successful expansions into Europe and strong M&A activity, Climb positions itself as a niche player supporting digital transformation initiatives, appealing to institutional investors and strategic buyers alike.
May 30, 2025 - 4:00 PM EST
Buy Long - EVLV @5.46
Evolv Technologies is at the forefront of revolutionizing physical security through its AI-driven, touchless weapon detection systems, increasingly adopted by schools, sports venues, and corporate campuses. The company continues to grow rapidly, with ARR up 129% YoY to $65.8M and a 59.8% subscription gross margin. Evolv added 75 new customers last quarter and has a 3–5 year revenue CAGR forecast of ~28.5%. While it faced scrutiny over past marketing, those issues are resolved, and adoption of its AI threat detection tech is expanding across schools, stadiums, and public infrastructure, making it a compelling early-stage security disruptor.
May 30, 2025 - 4:00 PM EST
Buy Long - INOD @39.47
Innodata, once a legacy IT firm, has repositioned itself as a major AI and data engineering provider, especially for medical and enterprise use cases. In 2024, the stock surged 436%, driven by 83% revenue growth across the first nine months and several new enterprise clients. Innodata’s AI platform, which handles sensitive structured data, is increasingly in demand for generative AI and machine learning applications.
May 30, 2025 - 4:00 PM EST
Buy Long - APLD @6.83
Applied Digital develops high-performance data centers tailored for blockchain, AI, and cloud computing. While shares recently traded at $4.41, analysts estimate an average 126.8% upside based on strong fundamentals and a multi-gigawatt pipeline. Despite some setbacks—like a transformer issue at one facility—the company’s commitment to infrastructure at scale aligns with growing demand for AI processing power.
May 30, 2025 - 4:00 PM EST
Buy Long - FIP @6.11
FTAI Infrastructure owns and operates U.S.-based transport and energy assets, including ports and hydrogen transition projects. Revenue is projected to jump 24% from $373M in 2024 to $464M in 2025, signaling aggressive growth. With exposure to clean energy infrastructure and government-funded construction, FIP offers long-duration upside with the benefit of hard-asset backing—rare for a small-cap.
May 30, 2025 - 4:00 PM EST
Buy Long - AVAV @178.03
AeroVironment is a market leader in small unmanned aerial systems (UAS), including its Switchblade loitering missiles, which earned it a $990M contract with the U.S. Army. The defense drone market is projected to grow at a 22.2% CAGR to $82.9B by 2032, and AeroVironment is a top U.S.-based pure-play. With rising geopolitical tensions and NATO defense spend increasing, AVAV has a favorable multi-year runway.
May 30, 2025 - 4:00 PM EST
Buy Long - RYTM @61.33
Rhythm focuses on rare genetic obesity disorders and is gaining traction with its lead therapy Imcivree. In Q1 2025, revenue grew 26% year-over-year to $32.7M, while losses narrowed significantly (from $2.35 to $0.81 per share). Analysts project breakeven by 2026. With strong institutional support and expanding market access in Europe and the U.S., Rhythm could benefit significantly from rising demand for weight-loss biotech.
May 30, 2025 - 4:00 PM EST
Buy Long - SKYW @101.45
SkyWest is a regional airline operating under contract for major carriers like Delta, United, and American. The company is rebounding alongside domestic air travel and has managed fleet upgrades efficiently post-COVID. Despite macro turbulence in aviation, SkyWest’s regional focus and partner diversification make it a strategic mid-cap to watch. Airline demand is expected to remain elevated through 2026, especially for regional routes.
May 30, 2025 - 4:00 PM EST
Buy Long - NVDA @135.13
NVIDIA is the global leader in GPUs and AI semiconductors, and arguably the most critical infrastructure company in the AI boom. As of Q1 FY2026 (reported May 2025), NVIDIA delivered record quarterly revenue of $26.04B, up 262% year-over-year, with data center revenue up 427%, driven by explosive demand for its H100 and upcoming Blackwell B200 AI chips. The company holds a near-monopoly on advanced AI hardware and has expanded its moat with CUDA software, the Omniverse platform, and custom AI accelerators for sovereign AI projects. With U.S. and global governments pouring billions into AI sovereignty and data center buildouts, NVIDIA remains the core enabling layer of next-gen computing — a foundational compounder with asymmetric upside despite a $2.7T market cap.